0001062993-16-011353.txt : 20160830
0001062993-16-011353.hdr.sgml : 20160830
20160830191648
ACCESSION NUMBER: 0001062993-16-011353
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160830
FILED AS OF DATE: 20160830
DATE AS OF CHANGE: 20160830
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Thomas
CENTRAL INDEX KEY: 0001355189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 161861675
MAIL ADDRESS:
STREET 1: 1764 BRIAR PLACE
CITY: MERRICK
STATE: NY
ZIP: 11566
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2016-08-30
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001355189
Wegman Thomas
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
1
1
0
President
Common Stock, $.001 par value
2016-08-30
4
M
0
25000
0.83
A
212549
D
Common Stock, $.001 par value
2016-08-30
4
M
0
100000
0.83
A
312549
D
Stock Option (Right to Buy)
0.83
2016-08-30
4
M
0
25000
0
D
2006-09-06
2016-09-05
Common Stock, $.001 par value
25000
0
D
Stock Option (Right to Buy)
0.83
2016-08-30
4
M
0
100000
0
D
2016-09-05
Common Stock, $.001 par value
100000
0
D
On September 6, 2006, the reporting person was granted an option to purchase 100,000 shares of the Issuer's Common Stock. The option vested in two equal installments based on the reporting person's satisfaction of two distinct performance conditions. The first performance related condition was satisfied on October 24, 2007, resulting in the vesting of the option as to 50,000 shares. The second performance related condition was satisfied on April 2, 2010, resulting in the vesting of the option as to the remaining 50,000 shares.
/s/ Carl A. Valenstein, attorney-in-fact for Thomas Wegman
2016-08-30